Identification of highly efficacious PROTACs targeting BRD4 against acute myeloid leukemia: Design, synthesis, and biological evaluations
Author:
Funder
Special Project for Research and Development in Key areas of Guangdong Province
National Natural Science Foundation of China
Publisher
Elsevier BV
Subject
General Chemistry
Reference34 articles.
1. Acute myeloid leukaemia
2. Small-Molecule Fms-like Tyrosine Kinase 3 Inhibitors: An Attractive and Efficient Method for the Treatment of Acute Myeloid Leukemia
3. Cancer statistics, 2022
4. Benefit of high-dose idarubicin as induction therapy in acute myeloid leukemia: a prospective phase 2 study
5. Potent Dual BET/HDAC Inhibitors for Efficient Treatment of Pancreatic Cancer
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Developing selective PI3K degraders to modulate both kinase and non-kinase functions;CHINESE CHEM LETT;2024
2. Red blood cell membrane-coated FLT3 inhibitor nanoparticles to enhance FLT3-ITD acute myeloid leukemia treatment;Chinese Chemical Letters;2024-09
3. Hydrophobic tagging-induced degradation of NAMPT in leukemia cells;Chinese Chemical Letters;2023-12
4. Hydrophobic tag tethering degrader as a promising paradigm of protein degradation: past, present and future perspectives;Chinese Chemical Letters;2023-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3